TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 101 filers reported holding TG THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $241,000 | -7.3% | 5,000 | 0.0% | 0.02% | -13.8% |
| Q4 2020 | $260,000 | +33.3% | 5,000 | -50.0% | 0.03% | +7.4% |
| Q2 2020 | $195,000 | +99.0% | 10,000 | 0.0% | 0.03% | +92.9% |
| Q1 2020 | $98,000 | -65.1% | 10,000 | -80.0% | 0.01% | -53.3% |
| Q3 2019 | $281,000 | -35.1% | 50,000 | 0.0% | 0.03% | -36.2% |
| Q2 2019 | $433,000 | +7.7% | 50,000 | 0.0% | 0.05% | +11.9% |
| Q1 2019 | $402,000 | +96.1% | 50,000 | 0.0% | 0.04% | +82.6% |
| Q4 2018 | $205,000 | -77.1% | 50,000 | -68.8% | 0.02% | -74.7% |
| Q3 2018 | $896,000 | -57.4% | 160,000 | 0.0% | 0.09% | -60.8% |
| Q2 2018 | $2,104,000 | -7.4% | 160,000 | 0.0% | 0.23% | -13.1% |
| Q1 2018 | $2,272,000 | +73.2% | 160,000 | 0.0% | 0.27% | +72.3% |
| Q4 2017 | $1,312,000 | -30.8% | 160,000 | 0.0% | 0.16% | -36.7% |
| Q3 2017 | $1,896,000 | +214.4% | 160,000 | +166.7% | 0.24% | +202.5% |
| Q2 2017 | $603,000 | -13.7% | 60,000 | 0.0% | 0.08% | -18.2% |
| Q1 2017 | $699,000 | – | 60,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 839,128 | $27,926,000 | 5.24% |
| RA Capital Management | 4,098,332 | $136,392,000 | 1.89% |
| KLK CAPITAL MANAGEMENT LLC | 45,762 | $1,523,000 | 1.40% |
| Antara Capital LP | 520,800 | $17,332,000 | 1.33% |
| Spotlight Asset Group, Inc. | 75,000 | $2,496,000 | 1.24% |
| Nicholas Investment Partners, LP | 485,838 | $16,169,000 | 1.18% |
| MAVERICK CAPITAL LTD | 3,296,451 | $109,706,000 | 1.11% |
| SECTORAL ASSET MANAGEMENT INC | 394,949 | $13,144,000 | 1.09% |
| 683 Capital Management, LLC | 828,271 | $27,565,000 | 1.08% |
| ACT CAPITAL MANAGEMENT, LLC | 60,000 | $1,997,000 | 1.04% |